Navigation Links
Urologist and Allergist Explore Link Between Allergies and Interstitial Cystitis
Date:6/19/2009

Findings point to new treatment options and research directions

WASHINGTON, June 19 /PRNewswire-USNewswire/ -- Allergy testing and treatment may offer a new therapeutic option for many patients with interstitial cystitis (IC). IC is a severely painful bladder condition affecting as many as 8 million women and 1.5 million men in the United States. Patients and the providers who treat them have long noticed a correlation between allergies and IC. Recently, a urologist and allergist in Louisville, Kentucky, began to explore the link between these two chronic ailments to provide patients with more effective treatment. The story of their discoveries is featured in the ICA Update, the quarterly magazine of the Interstitial Cystitis Association (ICA).

"Until now, the evidence linking IC and allergies has been circumstantial," said Barbara Gordon, executive director of the ICA, an organization providing advocacy, research funding, and education to ensure early diagnosis and optimal care with dignity for people affected by IC. "Epidemiologic studies show the prevalence of allergies in IC patients to be higher than in people in general. Anti-allergy medications seem to ease IC symptoms, especially when patients have seasonal allergies. And during allergy seasons, doctors report an upswing in IC-related calls and patient visits."

That suggests that there is a correlation between allergies and IC, but can allergies cause bladder symptoms? A clearer answer comes from actual allergy testing and treatment of patients. After holding several discussions on this subject, John Hubbard, M.D., a urologist, and C. Steven Smith, M.D., an allergist/immunologist, partnered to study this phenom
'/>"/>

SOURCE Interstitial Cystitis Association
Copyright©2009 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Surveyed Neurologists Anticipate That Less Than 30 Percent of Their Use of Emerging Oral Agents in Multiple Sclerosis Will be in the First Line
2. A Worldwide Phase III Clinical Trial Seeks U.S. Patients to Explore Investigational Drug Phenoxodiol
3. SPIRIT II Explores Long-Term Performance of XIENCE V Stent
4. New Survey Explores the Impact of Insulin Injections and Communications Between Patients and Healthcare Providers
5. 42 Top U.S. Scientists and Specialists Explore Cutting-Edge Innovations to Defend America From Dangerous Zoonotic Diseases
6. Research Explores the Effects of Stem Cell Source and Patient Age on Stem Cell Transplantation Outcomes
7. Studies Suggest Key Correlation Between Lung Cancer Subtype and Treatment Outcomes
8. Mayo Clinic Study Finds Further Association Between Diabetes and Pancreatic Cancer
9. CASTLE Study Showed Similar Efficacy Between Once-Daily REYATAZ(R) (atazanavir sulfate)/ritonavir and Twice-Daily lopinavir/ritonavir at 48 Weeks in Previously Untreated HIV-Infected Adult Patients
10. Cell Genesys Reports Association Between Immune Response and Patient Survival in Phase 2 Trial of GVAX Immunotherapy for Prostate Cancer
11. UM Maryland Industrial Partnerships Program Approves 18 Collaborative Research Projects, Worth $4.4 Million, Between University Faculty, State Technology Companies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... 2013  Recent regulatory and budget challenges have made ... at large pharmaceutical companies to effectively educate doctors and ... of their new products. With the pressure to reduce ... that these "Med Ed" groups find practical, ... address the changes that are transforming the Medical Education ...
(Date:6/18/2013)... , June 18, 2013 Unilife Corporation ... based designer, developer and manufacturer of injectable drug delivery ... website at www.unilife.com . The new site includes ... updates to occur on a regular basis. ... stated, "As an emerging global leader for injectable drug ...
(Date:6/18/2013)... , June 18, 2013  Specialty ... significant breakthrough in Parylene coating technologies: SCS ... the benefits of Parylene with antimicrobial properties ... devices and components. (Logo: ... infections (HAIs) increase and continue to pose ...
Breaking Medicine Technology:Though Vital to Educating Doctors on New Products, Pharma "Med Ed" Groups Working Under Huge Internal & External Constraints 2Unilife Launches New Corporate Website 2Specialty Coating Systems Announces New Antimicrobial Parylene Technology 2
... All pre-specified subset analyses of progression-free survival,in the ... in,relative risk of disease progression for patients receiving,satraplatin. ... as presence or absence of pain. -- The ... - radiologic,progression and pain progression - were each ...
... ,Abstracts: 2000, 2002 , CHICAGO/DARMSTADT, Germany, June 4, ... today at the American Society of,Clinical Oncology (ASCO) ... cilengitide in patients with newly diagnosed,glioblastoma – a ... highly selective integrin inhibitor targeting the,tumor and its ...
Cached Medicine Technology:Additional New Data from Satraplatin SPARC Phase 3 Investigational,Trial Presented at ASCO Annual Meeting 2Additional New Data from Satraplatin SPARC Phase 3 Investigational,Trial Presented at ASCO Annual Meeting 3Additional New Data from Satraplatin SPARC Phase 3 Investigational,Trial Presented at ASCO Annual Meeting 4Additional New Data from Satraplatin SPARC Phase 3 Investigational,Trial Presented at ASCO Annual Meeting 5Additional New Data from Satraplatin SPARC Phase 3 Investigational,Trial Presented at ASCO Annual Meeting 6Additional New Data from Satraplatin SPARC Phase 3 Investigational,Trial Presented at ASCO Annual Meeting 7Merck at ASCO 2007: Encouraging Results in Progression-Free,Survival in Patients With Aggressive Brain Tumors (glioblastoma),Using Cilengitide in Phase I/IIa Study 2Merck at ASCO 2007: Encouraging Results in Progression-Free,Survival in Patients With Aggressive Brain Tumors (glioblastoma),Using Cilengitide in Phase I/IIa Study 3Merck at ASCO 2007: Encouraging Results in Progression-Free,Survival in Patients With Aggressive Brain Tumors (glioblastoma),Using Cilengitide in Phase I/IIa Study 4Merck at ASCO 2007: Encouraging Results in Progression-Free,Survival in Patients With Aggressive Brain Tumors (glioblastoma),Using Cilengitide in Phase I/IIa Study 5
(Date:6/19/2013)... has been pushed to the brink of extinction but ... the big questions which a Bristol academic addresses in his ... of Medicine at the University of Bristol, has produced the ... with fear: the story of polio explores the experiences of ... of the disease. , According to a review ...
(Date:6/19/2013)... 2013 Ultimate Medical Academy (UMA) participated ... broadcast on WFLA News Channel 8. Since its inaugural ... $84 million for All Children's Hospital in St. Petersburg, ... Years of Miracles," marked the second year UMA volunteered ... worked the phones during the Telethon, which raised a ...
(Date:6/19/2013)... Imprivata ®, a leading global provider of ... OneSign ® leads the single sign-on (SSO) category in ... Services report . CIOs and other healthcare executives iwere ... of its products and the quality of its customer ... integral to their long-term healthcare IT strategy. , ...
(Date:6/19/2013)... June 19, 2013 Maui'd Forever ... dedicated to being an effective and cost effective way ... They have partnered up with Tom Barefoot’s Tours providing ... on most of Hawaii’s activities. , They have just ... can get the lowest prices on their Hawaii activities. ...
(Date:6/19/2013)... (PRWEB) June 19, 2013 The producers of ... dates for Phoenix, Arizona. The city is located in ... Sun”. It has shed its frontier image and become an ... It is the fifth-largest city in the United States with ... industries. It offers residents a low cost-of-living, friendly business environment ...
Breaking Medicine News(10 mins):Health News:Paralysed with fear: The story of polio 2Health News:Ultimate Medical Academy Rallies in Support of All Children's Hospital 2Health News:Ultimate Medical Academy Rallies in Support of All Children's Hospital 3Health News:Imprivata Tops Single Sign-On Category in KLAS 2013 Mid-Term Performance Review 2Health News:Imprivata Tops Single Sign-On Category in KLAS 2013 Mid-Term Performance Review 3Health News:Maui'd Forever Pleased to Offer Price Guarantee on Hawaii Activities 2Health News:Viewpoints TV Announces June Air Dates for Phoenix, AZ 2
... in the treatment of strokes according to a report released in ... the cord blood could heal strokes almost 80% faster based on ... be worked out and the project itself is in a primitive ... R. Sanberg from the university of South Florida conducted the study. ...
... exclusive to the blessed. The less fortunate are those ... early morning headaches or serious daytime fatigue. Among the ... moderate form is commonly experienced. Sleep apnea is a ... Most individuals may have less severe sleep related breathing ...
... quake-devastated state of,Gujarat in India is now slowly coming ... different news channels and papers are busy increasing the,death ... state government and,the central government are now faced with ... hospitals are crammed with patients and doctors are,desperately needed ...
... have an eating disorder when compared with non-diabetic girls. ... than their prescribed dose of insulin in order to ... onset of diabetes related complications and are associated with ... diabetes could be the risk factor for developing eating ...
... at the just concluded Indian science congress in New Delhi ... combat anemia with iron fortification of crops. Almost 50% of ... anemic in India. While iron supplementation is expensive, fortification of ... anemia in people is fairly cheaper, scientists say. ,This ...
... related tissue experiences ischemia, a state of low oxygen supply ... / Reperfusion (IR) injury occurs during heart attacks. ,Understanding ... to save the damaged tissue and treat heart attack. During ... increases and acts like a common link between the pathways ...
Cached Medicine News:Health News:Doctors needed urgently in Gujarat 2Health News:Doctors needed urgently in Gujarat 3Health News:Doctors needed urgently in Gujarat 4
...
...
...
... The Premier Anterior Cervical Plate System ... screw translation along slots in the ... the distal end of the construct. ... has graft pre-compression features that enable ...
Medicine Products: